Officer sold ~$2.29M of Thermo Fisher Scientific
Scheduled in advanceTMO · NYSE · Life Sciences Tools & Services
Life Sciences Tools & Services company based in Waltham, Massachusetts.
Last close, Oct 1, 2026
$652.51
Adjusted for splits and dividends
Last 12 months
+22.9%
S&P 500 +14.3% over the same dates
Market value
$241B
Last close × shares outstanding
Bets against the stock: 5.02M shares sold short (1.4% of shares outstanding), -11.8% vs the previous count, 2.7 days of normal trading to buy them back. FINRA, as of Sep 15, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
93 sales
$61.6M sold. Insiders sell for many reasons.
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2025
$44.6B
+3.9% vs the year before
Net income, fiscal 2025
$6.7B
As reported in the annual filing
Shares outstanding
370M
As of Jun 27, 2026
In fiscal 2025 the company spent $3B buying back its own shares and $636M on dividends. Cash actually paid, from its cash-flow statement.
Officer sold ~$2.29M of Thermo Fisher Scientific
Scheduled in advanceOfficer sold ~$246K of Thermo Fisher Scientific
Scheduled in advanceCEO sold ~$63K of Thermo Fisher Scientific
Scheduled in advanceCEO sold ~$39K of Thermo Fisher Scientific
Scheduled in advancePrices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
2 approvals or clearances and 0 recalls recorded by the FDA for this company and its listed subsidiaries.
From openFDA: Drugs@FDA (new applications and new uses), device 510(k) and PMA decisions, and FDA enforcement reports. Class I recalls are the most serious, Class III the least. Most recalls are started by the company itself. Labeling and manufacturing changes are not listed.
4 notices filed with state agencies, covering 317 workers in total. Employers must warn the state ahead of a plant closing or mass layoff at a site.
Official WARN lists from California, Texas, New York, Florida, Illinois and Washington only; notices filed in other states are not shown. Matched on the employer name as filed, so a notice filed under an unrelated subsidiary name can be missing. Dates are the notice date (Washington: the date the state received it).
65 certified in FY2026 Q3, vs 73 a year earlier. 65 positions in total, median offered wage $121K a year.
Labor condition applications for H-1B workers certified by the Department of Labor, counted by decision date (FY2026 Q3: Apr 1, 2026 to Jun 30, 2026, the latest quarter published). A certified application is a step before a visa petition, not a hire or a visa, and one application can cover several positions. Matched by employer ID number or name.
Federal rules, proposed rules and notices that name the company by its legal name, from the Federal Register. Being named is not the same as being the target of a rule.
Last 12 months, adjusted daily closes
Adjusted close went from $530.73 on Oct 1, 2025 to $652.51 on Oct 1, 2026 (+22.9%). Disclosed trades in the last 12 months: 0 insider purchases, 160 insider sales (149 under pre-arranged plans), 2 Congress purchases, 4 Congress sales.
Anyone owning more than 5% must file within days. Structured filings exist since December 2024, so older stakes that were never amended may be missing.
Short sale volume: 51.4% of the volume reported to FINRA over the last 20 trading days was marked short, above its 1-year average of 45.0%. FINRA daily files, to Oct 2, 2026.
Fails to deliver: 2,900 shares (about $1.82M) were not delivered on time for settlement on Aug 24, 2026. SEC fails-to-deliver data.
Short sale volume is not short interest. It counts trades marked short, including market makers selling short to fill buy orders, so it is a share of daily trading, not a count of bets against the stock. Fails to deliver have many causes, including processing delays, and are often resolved within days.